Approval makes Gomekli the first treatment to be approved for both adults and pediatric patients for neurofibromatosis type 1 ...

Describing the Aynaghor (secret torture cells) as horrific, Chief Adviser Professor Muhammad Yunus on Wednesday said the ...

The FDA's green light for GOMEKLI is a significant achievement for SpringWorks, especially as it comes with a rare pediatric disease priority review voucher, which could be valued at around $100 ...